| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fiber Optic Technology | 53 | 2013 | 290 | 6.810 |
Why?
|
| Protein Array Analysis | 17 | 2020 | 411 | 4.040 |
Why?
|
| Biosensing Techniques | 33 | 2023 | 668 | 3.940 |
Why?
|
| beta-Galactosidase | 11 | 2018 | 573 | 3.920 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 18 | 2023 | 3870 | 2.970 |
Why?
|
| Saliva | 13 | 2022 | 809 | 2.900 |
Why?
|
| Immunoassay | 12 | 2021 | 752 | 2.750 |
Why?
|
| Microspheres | 22 | 2017 | 777 | 2.540 |
Why?
|
| Optical Fibers | 33 | 2013 | 138 | 2.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 21 | 2017 | 3920 | 2.180 |
Why?
|
| Proteins | 15 | 2023 | 6103 | 2.160 |
Why?
|
| Alkaline Phosphatase | 4 | 2023 | 865 | 2.080 |
Why?
|
| Nanotechnology | 11 | 2020 | 710 | 1.980 |
Why?
|
| Cytokines | 12 | 2023 | 7322 | 1.870 |
Why?
|
| Hypophosphatasia | 2 | 2023 | 14 | 1.760 |
Why?
|
| Antibodies, Viral | 14 | 2024 | 3176 | 1.540 |
Why?
|
| Salivary Proteins and Peptides | 4 | 2014 | 53 | 1.490 |
Why?
|
| Antibodies | 7 | 2024 | 2460 | 1.380 |
Why?
|
| Microarray Analysis | 10 | 2009 | 767 | 1.360 |
Why?
|
| Antigens, Viral | 4 | 2023 | 1035 | 1.290 |
Why?
|
| Microfluidic Analytical Techniques | 7 | 2018 | 828 | 1.250 |
Why?
|
| Limit of Detection | 9 | 2021 | 265 | 1.220 |
Why?
|
| Smell | 6 | 2011 | 244 | 1.120 |
Why?
|
| Myocarditis | 2 | 2023 | 771 | 1.050 |
Why?
|
| Spectrometry, Fluorescence | 5 | 2012 | 689 | 1.030 |
Why?
|
| Chemistry Techniques, Analytical | 4 | 2009 | 49 | 0.950 |
Why?
|
| DNA | 14 | 2023 | 7301 | 0.900 |
Why?
|
| Biotin | 5 | 2018 | 254 | 0.890 |
Why?
|
| Surface Properties | 10 | 2021 | 1184 | 0.860 |
Why?
|
| Escherichia coli | 12 | 2018 | 4217 | 0.840 |
Why?
|
| DNA Probes | 9 | 2007 | 560 | 0.840 |
Why?
|
| Multiple System Atrophy | 1 | 2024 | 121 | 0.840 |
Why?
|
| Nucleic Acids | 4 | 2017 | 182 | 0.830 |
Why?
|
| Kinetics | 15 | 2021 | 6473 | 0.800 |
Why?
|
| Fluorescent Dyes | 16 | 2013 | 1917 | 0.800 |
Why?
|
| Diagnosis | 2 | 2015 | 154 | 0.800 |
Why?
|
| Optical Tweezers | 2 | 2013 | 79 | 0.790 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2021 | 40 | 0.780 |
Why?
|
| Parkinson Disease | 4 | 2024 | 2775 | 0.780 |
Why?
|
| DNA Restriction Enzymes | 1 | 2021 | 570 | 0.770 |
Why?
|
| Cross Reactions | 3 | 2020 | 841 | 0.760 |
Why?
|
| DNA Cleavage | 1 | 2021 | 58 | 0.760 |
Why?
|
| Biological Warfare | 3 | 2006 | 24 | 0.750 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2020 | 65 | 0.740 |
Why?
|
| Indicators and Reagents | 3 | 2018 | 462 | 0.730 |
Why?
|
| Microchemistry | 5 | 2010 | 57 | 0.730 |
Why?
|
| Fetal Proteins | 1 | 2020 | 94 | 0.730 |
Why?
|
| Neutralization Tests | 1 | 2021 | 758 | 0.700 |
Why?
|
| Enzyme Assays | 1 | 2020 | 111 | 0.700 |
Why?
|
| alpha-Synuclein | 2 | 2024 | 723 | 0.690 |
Why?
|
| Biological Assay | 3 | 2020 | 652 | 0.680 |
Why?
|
| Quantum Dots | 3 | 2021 | 172 | 0.680 |
Why?
|
| Oligonucleotides | 3 | 2017 | 572 | 0.670 |
Why?
|
| Polymers | 7 | 2018 | 1621 | 0.670 |
Why?
|
| Microscopy, Fluorescence | 12 | 2016 | 2699 | 0.650 |
Why?
|
| Protein Subunits | 2 | 2020 | 959 | 0.650 |
Why?
|
| Lipoproteins | 1 | 2023 | 878 | 0.630 |
Why?
|
| Fibrin | 1 | 2020 | 506 | 0.620 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 471 | 0.610 |
Why?
|
| Nucleic Acid Hybridization | 8 | 2008 | 1375 | 0.600 |
Why?
|
| Chromatography, Gel | 3 | 2023 | 668 | 0.600 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2011 | 1122 | 0.590 |
Why?
|
| Chordoma | 1 | 2020 | 359 | 0.580 |
Why?
|
| DNA, Bacterial | 3 | 2013 | 1465 | 0.580 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2007 | 2752 | 0.570 |
Why?
|
| Thrombin | 2 | 2014 | 598 | 0.560 |
Why?
|
| Nose | 4 | 2011 | 509 | 0.560 |
Why?
|
| Aptamers, Nucleotide | 2 | 2016 | 166 | 0.550 |
Why?
|
| Dinoprostone | 1 | 2018 | 600 | 0.540 |
Why?
|
| Sensitivity and Specificity | 20 | 2022 | 14722 | 0.530 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3597 | 0.530 |
Why?
|
| Isoenzymes | 1 | 2020 | 1726 | 0.530 |
Why?
|
| Ricin | 1 | 2015 | 72 | 0.530 |
Why?
|
| Telomerase | 1 | 2020 | 730 | 0.520 |
Why?
|
| Hydrogels | 1 | 2020 | 724 | 0.510 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 517 | 0.500 |
Why?
|
| Computational Biology | 2 | 2017 | 3521 | 0.490 |
Why?
|
| Chemokine CXCL10 | 1 | 2015 | 304 | 0.480 |
Why?
|
| Kallikreins | 1 | 2015 | 258 | 0.460 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 440 | 0.460 |
Why?
|
| Humans | 91 | 2024 | 744343 | 0.460 |
Why?
|
| Molecular Biology | 1 | 2017 | 596 | 0.460 |
Why?
|
| RNA, Viral | 2 | 2022 | 2902 | 0.450 |
Why?
|
| Escherichia coli O157 | 1 | 2013 | 54 | 0.450 |
Why?
|
| Molecular Probe Techniques | 3 | 2007 | 119 | 0.450 |
Why?
|
| Electrochemistry | 3 | 2009 | 145 | 0.450 |
Why?
|
| Protein Multimerization | 1 | 2018 | 970 | 0.450 |
Why?
|
| Protein Kinases | 1 | 2020 | 1640 | 0.450 |
Why?
|
| Optics and Photonics | 5 | 2008 | 321 | 0.450 |
Why?
|
| Dengue Virus | 1 | 2015 | 204 | 0.440 |
Why?
|
| Luminescence | 1 | 2013 | 137 | 0.430 |
Why?
|
| Microfluidics | 3 | 2021 | 662 | 0.430 |
Why?
|
| Luminescent Measurements | 4 | 2009 | 405 | 0.430 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 708 | 0.430 |
Why?
|
| Interleukin-8 | 1 | 2015 | 690 | 0.420 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1061 | 0.420 |
Why?
|
| Curriculum | 3 | 2016 | 3605 | 0.420 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 638 | 0.410 |
Why?
|
| Oils | 1 | 2012 | 63 | 0.410 |
Why?
|
| Colorimetry | 2 | 2011 | 147 | 0.410 |
Why?
|
| Equipment and Supplies | 1 | 2014 | 281 | 0.410 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.410 |
Why?
|
| Fluorescence | 6 | 2016 | 751 | 0.410 |
Why?
|
| Dengue | 1 | 2015 | 256 | 0.400 |
Why?
|
| Receptors, Odorant | 2 | 2011 | 61 | 0.390 |
Why?
|
| Horseradish Peroxidase | 2 | 2009 | 166 | 0.390 |
Why?
|
| Miniaturization | 2 | 2017 | 164 | 0.390 |
Why?
|
| Informatics | 1 | 2011 | 72 | 0.390 |
Why?
|
| Oligonucleotide Probes | 5 | 2008 | 427 | 0.390 |
Why?
|
| Calibration | 4 | 2020 | 816 | 0.390 |
Why?
|
| Ruthenium | 3 | 2007 | 22 | 0.390 |
Why?
|
| Gases | 2 | 2009 | 197 | 0.380 |
Why?
|
| Hydrocortisone | 1 | 2018 | 1826 | 0.380 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3200 | 0.370 |
Why?
|
| COS Cells | 2 | 2023 | 1161 | 0.370 |
Why?
|
| Corrosion | 2 | 2002 | 29 | 0.360 |
Why?
|
| Microscopy, Electron, Scanning | 7 | 2014 | 964 | 0.360 |
Why?
|
| Students | 2 | 2017 | 1654 | 0.360 |
Why?
|
| Quorum Sensing | 1 | 2011 | 131 | 0.360 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 2505 | 0.350 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1276 | 0.350 |
Why?
|
| Logic | 1 | 2009 | 39 | 0.350 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2015 | 738 | 0.340 |
Why?
|
| Chemistry, Analytic | 1 | 2008 | 1 | 0.340 |
Why?
|
| Prostate-Specific Antigen | 3 | 2016 | 2494 | 0.340 |
Why?
|
| Neoplasms | 5 | 2021 | 21683 | 0.330 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 783 | 0.330 |
Why?
|
| Enzymes | 2 | 2007 | 266 | 0.330 |
Why?
|
| Reagent Strips | 1 | 2008 | 39 | 0.320 |
Why?
|
| Information Storage and Retrieval | 2 | 2011 | 824 | 0.320 |
Why?
|
| Immunoglobulin G | 7 | 2023 | 4560 | 0.320 |
Why?
|
| Nitrites | 1 | 2008 | 160 | 0.320 |
Why?
|
| Disease Progression | 3 | 2023 | 13284 | 0.320 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 1050 | 0.310 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2021 | 363 | 0.310 |
Why?
|
| Respiratory Tract Diseases | 1 | 2013 | 722 | 0.310 |
Why?
|
| Nanoparticles | 3 | 2014 | 1905 | 0.310 |
Why?
|
| Biochemistry | 1 | 2008 | 113 | 0.310 |
Why?
|
| Spectrophotometry | 1 | 2008 | 313 | 0.300 |
Why?
|
| Organisms, Genetically Modified | 1 | 2007 | 64 | 0.300 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1738 | 0.300 |
Why?
|
| Mutagens | 2 | 2005 | 168 | 0.290 |
Why?
|
| Eutrophication | 1 | 2006 | 2 | 0.290 |
Why?
|
| Phytoplankton | 1 | 2006 | 4 | 0.290 |
Why?
|
| Learning | 1 | 2017 | 1713 | 0.290 |
Why?
|
| Cells | 2 | 2005 | 168 | 0.290 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 323 | 0.290 |
Why?
|
| Solutions | 3 | 2016 | 426 | 0.290 |
Why?
|
| Genome, Human | 2 | 2018 | 4420 | 0.290 |
Why?
|
| Environmental Monitoring | 3 | 2005 | 1414 | 0.290 |
Why?
|
| Cystic Fibrosis | 1 | 2015 | 1177 | 0.280 |
Why?
|
| Particle Size | 3 | 2020 | 1642 | 0.280 |
Why?
|
| Pattern Recognition, Automated | 2 | 2011 | 1005 | 0.280 |
Why?
|
| Biology | 1 | 2008 | 294 | 0.280 |
Why?
|
| Substrate Specificity | 4 | 2021 | 1801 | 0.270 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5097 | 0.270 |
Why?
|
| Microscopy | 2 | 2009 | 903 | 0.270 |
Why?
|
| Eukaryota | 1 | 2006 | 99 | 0.270 |
Why?
|
| Oxygen | 4 | 2007 | 4189 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 2011 | 2557 | 0.260 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 3587 | 0.260 |
Why?
|
| Genetic Engineering | 1 | 2011 | 951 | 0.260 |
Why?
|
| Diagnostic Equipment | 1 | 2005 | 10 | 0.260 |
Why?
|
| Immunoglobulin M | 3 | 2021 | 1537 | 0.260 |
Why?
|
| Bacteria | 3 | 2005 | 2114 | 0.260 |
Why?
|
| Genes, Fungal | 1 | 2006 | 455 | 0.260 |
Why?
|
| Gold Colloid | 1 | 2004 | 13 | 0.250 |
Why?
|
| Salmonella | 1 | 2005 | 129 | 0.250 |
Why?
|
| Enzymes, Immobilized | 3 | 1997 | 48 | 0.250 |
Why?
|
| Animals | 29 | 2023 | 168757 | 0.250 |
Why?
|
| Catalysis | 3 | 2020 | 761 | 0.250 |
Why?
|
| Genomics | 4 | 2023 | 5720 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3508 | 0.240 |
Why?
|
| Bacterial Typing Techniques | 1 | 2005 | 256 | 0.240 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2008 | 2649 | 0.240 |
Why?
|
| Vaccinia virus | 1 | 2005 | 349 | 0.230 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 3798 | 0.230 |
Why?
|
| Models, Chemical | 2 | 2018 | 626 | 0.220 |
Why?
|
| Manduca | 1 | 2002 | 12 | 0.220 |
Why?
|
| Equipment Design | 5 | 2013 | 3582 | 0.220 |
Why?
|
| Apolipoprotein B-100 | 1 | 2023 | 148 | 0.220 |
Why?
|
| Nanopores | 1 | 2023 | 50 | 0.220 |
Why?
|
| Olfactory Pathways | 1 | 2003 | 121 | 0.210 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 11124 | 0.210 |
Why?
|
| Uric Acid | 1 | 2008 | 766 | 0.210 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1547 | 0.210 |
Why?
|
| Time Factors | 11 | 2021 | 40075 | 0.210 |
Why?
|
| Proteomics | 3 | 2022 | 3638 | 0.210 |
Why?
|
| Artificial Organs | 2 | 2001 | 204 | 0.210 |
Why?
|
| Dinitrobenzenes | 1 | 2001 | 37 | 0.210 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 1671 | 0.210 |
Why?
|
| Esterases | 1 | 2001 | 95 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5221 | 0.200 |
Why?
|
| Asthma | 4 | 2014 | 6011 | 0.200 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2022 | 248 | 0.200 |
Why?
|
| Plasma | 2 | 2022 | 575 | 0.200 |
Why?
|
| Ultracentrifugation | 1 | 2021 | 182 | 0.200 |
Why?
|
| Interleukin-2 | 2 | 2019 | 1904 | 0.200 |
Why?
|
| Nephropidae | 1 | 2021 | 71 | 0.200 |
Why?
|
| Aluminum | 1 | 2002 | 152 | 0.200 |
Why?
|
| Biomimetic Materials | 1 | 2003 | 179 | 0.200 |
Why?
|
| Centrifugation | 1 | 2021 | 122 | 0.200 |
Why?
|
| MicroRNAs | 1 | 2017 | 3752 | 0.200 |
Why?
|
| Soil Pollutants | 1 | 2001 | 71 | 0.190 |
Why?
|
| Proteome | 3 | 2022 | 1799 | 0.190 |
Why?
|
| Theophylline | 1 | 2001 | 132 | 0.190 |
Why?
|
| Disulfides | 1 | 2023 | 457 | 0.190 |
Why?
|
| Whooping Cough | 1 | 2021 | 82 | 0.190 |
Why?
|
| Immunity, Humoral | 2 | 2024 | 598 | 0.190 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2021 | 170 | 0.190 |
Why?
|
| Nasal Cavity | 1 | 2003 | 313 | 0.190 |
Why?
|
| Biotinylation | 1 | 2021 | 179 | 0.190 |
Why?
|
| Microscopy, Atomic Force | 2 | 1998 | 250 | 0.190 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 100 | 0.190 |
Why?
|
| Plasmids | 3 | 2018 | 2307 | 0.180 |
Why?
|
| Intubation | 1 | 2020 | 141 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2003 | 8949 | 0.180 |
Why?
|
| Haptoglobins | 1 | 2021 | 165 | 0.180 |
Why?
|
| Neuromuscular Junction | 1 | 2002 | 398 | 0.180 |
Why?
|
| Digoxin | 1 | 2001 | 250 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5442 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2019 | 3206 | 0.180 |
Why?
|
| Sea Urchins | 1 | 1999 | 46 | 0.180 |
Why?
|
| Fermentation | 3 | 1997 | 144 | 0.180 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 537 | 0.180 |
Why?
|
| Dioxygenases | 1 | 2021 | 316 | 0.180 |
Why?
|
| Stochastic Processes | 2 | 2013 | 344 | 0.170 |
Why?
|
| Penicillins | 2 | 1995 | 380 | 0.170 |
Why?
|
| Replantation | 1 | 2020 | 148 | 0.170 |
Why?
|
| Protein Isoforms | 2 | 2022 | 1730 | 0.170 |
Why?
|
| Measles | 1 | 2021 | 168 | 0.170 |
Why?
|
| Hepatitis B Vaccines | 1 | 2020 | 194 | 0.170 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 19905 | 0.170 |
Why?
|
| Temperature | 3 | 2019 | 2206 | 0.170 |
Why?
|
| Microelectrodes | 2 | 2002 | 303 | 0.170 |
Why?
|
| Quartz Crystal Microbalance Techniques | 1 | 2018 | 8 | 0.170 |
Why?
|
| Carcinogens | 1 | 2001 | 466 | 0.170 |
Why?
|
| Renal Dialysis | 1 | 2008 | 1786 | 0.170 |
Why?
|
| Albumins | 1 | 2021 | 569 | 0.170 |
Why?
|
| Ovum | 1 | 1999 | 189 | 0.160 |
Why?
|
| Education, Medical | 1 | 2011 | 1721 | 0.160 |
Why?
|
| Cerebrospinal Fluid | 1 | 2021 | 534 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 2 | 2008 | 2538 | 0.160 |
Why?
|
| Fertilization | 1 | 1999 | 196 | 0.160 |
Why?
|
| Image Enhancement | 1 | 2009 | 2921 | 0.160 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 992 | 0.160 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1101 | 0.160 |
Why?
|
| Acetate-CoA Ligase | 2 | 1988 | 11 | 0.160 |
Why?
|
| Oxazines | 3 | 2009 | 298 | 0.160 |
Why?
|
| Serum Albumin, Bovine | 1 | 2018 | 324 | 0.160 |
Why?
|
| Gene Expression | 2 | 2004 | 7799 | 0.160 |
Why?
|
| Coenzyme A Ligases | 2 | 1988 | 43 | 0.160 |
Why?
|
| Organ Preservation | 1 | 2020 | 331 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2011 | 3444 | 0.150 |
Why?
|
| Gadus morhua | 1 | 2017 | 2 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8037 | 0.150 |
Why?
|
| Vaccination | 4 | 2024 | 3278 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 3 | 2011 | 2088 | 0.150 |
Why?
|
| Reference Standards | 2 | 2018 | 1025 | 0.150 |
Why?
|
| Hepatitis B virus | 1 | 2020 | 513 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2021 | 1154 | 0.150 |
Why?
|
| Glutamic Acid | 1 | 2002 | 1169 | 0.140 |
Why?
|
| Antibody Formation | 1 | 2021 | 1402 | 0.140 |
Why?
|
| Penicillinase | 1 | 1995 | 9 | 0.140 |
Why?
|
| Cell Movement | 2 | 2006 | 5217 | 0.140 |
Why?
|
| Cattle | 2 | 2018 | 3922 | 0.140 |
Why?
|
| Volatilization | 2 | 2009 | 82 | 0.140 |
Why?
|
| Silicon Dioxide | 2 | 2009 | 213 | 0.140 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2019 | 694 | 0.140 |
Why?
|
| Cough | 1 | 2019 | 555 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13102 | 0.140 |
Why?
|
| Perfusion | 1 | 2020 | 1360 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15165 | 0.130 |
Why?
|
| Male | 19 | 2021 | 350118 | 0.130 |
Why?
|
| Education, Professional | 1 | 2016 | 54 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2001 | 1133 | 0.130 |
Why?
|
| Vibrio vulnificus | 1 | 2014 | 12 | 0.130 |
Why?
|
| Hepatitis B | 1 | 2020 | 695 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 903 | 0.130 |
Why?
|
| Extremities | 1 | 2020 | 865 | 0.130 |
Why?
|
| Glycomics | 1 | 2016 | 121 | 0.120 |
Why?
|
| Azides | 1 | 1994 | 116 | 0.120 |
Why?
|
| Immunotherapy | 2 | 2020 | 4445 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 738 | 0.120 |
Why?
|
| Lac Operon | 2 | 2005 | 238 | 0.120 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2005 | 129 | 0.120 |
Why?
|
| Species Specificity | 2 | 2011 | 2478 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2023 | 2035 | 0.120 |
Why?
|
| Antigens | 2 | 2009 | 1466 | 0.120 |
Why?
|
| Mitomycin | 2 | 2005 | 259 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2203 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2018 | 2126 | 0.120 |
Why?
|
| Models, Educational | 1 | 2017 | 377 | 0.120 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1901 | 0.120 |
Why?
|
| Quality Control | 2 | 2011 | 841 | 0.110 |
Why?
|
| Longevity | 1 | 2021 | 1070 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1184 | 0.110 |
Why?
|
| Heating | 1 | 2014 | 97 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1200 | 0.110 |
Why?
|
| Female | 17 | 2023 | 380194 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2019 | 810 | 0.110 |
Why?
|
| Triage | 1 | 2019 | 976 | 0.110 |
Why?
|
| Base Sequence | 5 | 2006 | 12797 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 4 | 2005 | 6171 | 0.110 |
Why?
|
| Molecular Conformation | 1 | 2014 | 563 | 0.110 |
Why?
|
| Spirometry | 1 | 2015 | 864 | 0.110 |
Why?
|
| Silanes | 1 | 2012 | 28 | 0.110 |
Why?
|
| DNA Primers | 1 | 1996 | 2892 | 0.100 |
Why?
|
| Education, Premedical | 1 | 2011 | 19 | 0.100 |
Why?
|
| Point Mutation | 1 | 1997 | 1623 | 0.100 |
Why?
|
| Chemical Warfare | 1 | 2011 | 18 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2375 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9274 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2020 | 2440 | 0.100 |
Why?
|
| Binding Sites | 2 | 2016 | 6114 | 0.100 |
Why?
|
| Food Analysis | 1 | 2011 | 104 | 0.100 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 1616 | 0.100 |
Why?
|
| Child | 6 | 2023 | 77709 | 0.100 |
Why?
|
| Genome, Viral | 1 | 2014 | 667 | 0.100 |
Why?
|
| Cell Line | 2 | 2020 | 15997 | 0.100 |
Why?
|
| Nanotubes, Carbon | 1 | 2011 | 73 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2022 | 1479 | 0.090 |
Why?
|
| Semiconductors | 1 | 2011 | 105 | 0.090 |
Why?
|
| School Admission Criteria | 1 | 2011 | 105 | 0.090 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1878 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2018 | 5179 | 0.090 |
Why?
|
| Water | 2 | 2012 | 1395 | 0.090 |
Why?
|
| Dogs | 2 | 2007 | 3912 | 0.090 |
Why?
|
| Hydrocharitaceae | 1 | 2009 | 2 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 3036 | 0.090 |
Why?
|
| Aluminum Oxide | 1 | 2009 | 42 | 0.090 |
Why?
|
| Reference Values | 1 | 2017 | 4982 | 0.090 |
Why?
|
| Lenses | 1 | 2010 | 45 | 0.090 |
Why?
|
| Ethanol | 2 | 2009 | 1342 | 0.090 |
Why?
|
| Metals, Alkali | 1 | 2009 | 2 | 0.090 |
Why?
|
| Chloroplasts | 1 | 2009 | 45 | 0.090 |
Why?
|
| Biophysics | 1 | 2011 | 383 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4751 | 0.090 |
Why?
|
| Middle Aged | 10 | 2021 | 213383 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1832 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2015 | 2716 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1990 | 0.090 |
Why?
|
| Adult | 12 | 2024 | 214055 | 0.090 |
Why?
|
| Collodion | 1 | 2009 | 34 | 0.090 |
Why?
|
| Protein Stability | 1 | 2011 | 557 | 0.090 |
Why?
|
| Gasoline | 1 | 2009 | 51 | 0.090 |
Why?
|
| Ink | 1 | 2009 | 44 | 0.090 |
Why?
|
| Absorption | 1 | 2009 | 248 | 0.090 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2011 | 214 | 0.090 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2012 | 215 | 0.090 |
Why?
|
| Bacterial Proteins | 3 | 2011 | 3848 | 0.090 |
Why?
|
| Fluorescein | 2 | 2001 | 171 | 0.080 |
Why?
|
| Free Radicals | 1 | 2009 | 237 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 15519 | 0.080 |
Why?
|
| Porosity | 1 | 2009 | 362 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 3507 | 0.080 |
Why?
|
| Nucleic Acid Conformation | 2 | 2004 | 913 | 0.080 |
Why?
|
| Coenzyme A | 1 | 1988 | 39 | 0.080 |
Why?
|
| Schools | 1 | 2016 | 1433 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 57776 | 0.080 |
Why?
|
| Galactosides | 1 | 2007 | 52 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25043 | 0.080 |
Why?
|
| Biomimetics | 1 | 2009 | 172 | 0.080 |
Why?
|
| Osteoarthritis, Hip | 1 | 2012 | 412 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2008 | 210 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 553 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 760 | 0.080 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2022 | 428 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 838 | 0.070 |
Why?
|
| Penicillium chrysogenum | 2 | 1997 | 7 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21746 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 274 | 0.070 |
Why?
|
| Glucose | 2 | 1997 | 4397 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4838 | 0.070 |
Why?
|
| Rats | 2 | 2017 | 24260 | 0.070 |
Why?
|
| Olfactory Mucosa | 1 | 2007 | 98 | 0.070 |
Why?
|
| Solvents | 1 | 2008 | 302 | 0.070 |
Why?
|
| Aged | 7 | 2021 | 163280 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.070 |
Why?
|
| Indicator Dilution Techniques | 1 | 2006 | 40 | 0.070 |
Why?
|
| Streptavidin | 1 | 2006 | 81 | 0.070 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2005 | 12 | 0.070 |
Why?
|
| Hydrolysis | 2 | 2011 | 682 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 868 | 0.070 |
Why?
|
| Seawater | 1 | 2006 | 121 | 0.070 |
Why?
|
| Bacillus thuringiensis | 1 | 2005 | 13 | 0.070 |
Why?
|
| Adolescent | 5 | 2023 | 85781 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 1940 | 0.070 |
Why?
|
| Rec A Recombinases | 1 | 2005 | 51 | 0.070 |
Why?
|
| Neurons | 2 | 2021 | 9338 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 464 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2008 | 247 | 0.070 |
Why?
|
| Lasers | 1 | 2010 | 952 | 0.070 |
Why?
|
| Food Microbiology | 1 | 2005 | 78 | 0.070 |
Why?
|
| Electrodes | 1 | 1987 | 619 | 0.070 |
Why?
|
| Health | 1 | 2008 | 394 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2008 | 566 | 0.060 |
Why?
|
| Algorithms | 3 | 2011 | 13881 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2010 | 1124 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 7722 | 0.060 |
Why?
|
| Schools, Medical | 1 | 2011 | 880 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 1889 | 0.060 |
Why?
|
| Poisson Distribution | 1 | 2006 | 513 | 0.060 |
Why?
|
| Mutation | 4 | 2023 | 29786 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 9648 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2006 | 502 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2014 | 2183 | 0.060 |
Why?
|
| Cell Communication | 1 | 2011 | 1621 | 0.060 |
Why?
|
| Carbocyanines | 1 | 2004 | 174 | 0.060 |
Why?
|
| 1-Propanol | 1 | 2003 | 15 | 0.060 |
Why?
|
| Educational Status | 1 | 2011 | 2540 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2000 | 9438 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 5867 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2008 | 1150 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 3047 | 0.060 |
Why?
|
| Air Pollutants | 2 | 2011 | 2817 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 1 | 2009 | 944 | 0.060 |
Why?
|
| Methanol | 1 | 2003 | 85 | 0.060 |
Why?
|
| Young Adult | 4 | 2023 | 56430 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1799 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 2187 | 0.050 |
Why?
|
| Ferrocyanides | 1 | 2002 | 3 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2023 | 242 | 0.050 |
Why?
|
| Salmon | 1 | 2002 | 36 | 0.050 |
Why?
|
| Molecular Imaging | 1 | 2009 | 828 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6773 | 0.050 |
Why?
|
| Rubella Vaccine | 1 | 2021 | 22 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2003 | 316 | 0.050 |
Why?
|
| Mumps Vaccine | 1 | 2021 | 17 | 0.050 |
Why?
|
| Metals, Heavy | 1 | 2003 | 139 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2023 | 338 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2005 | 509 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 401 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2017 | 6544 | 0.050 |
Why?
|
| Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2003 | 394 | 0.050 |
Why?
|
| Light | 2 | 1999 | 1374 | 0.050 |
Why?
|
| Alcoholic Beverages | 1 | 2003 | 265 | 0.050 |
Why?
|
| Immunochemistry | 1 | 2000 | 124 | 0.050 |
Why?
|
| Olfactory Bulb | 2 | 1999 | 200 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
| Lamivudine | 1 | 2022 | 342 | 0.050 |
Why?
|
| Warm Ischemia | 1 | 2020 | 53 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11031 | 0.050 |
Why?
|
| Mercury | 1 | 2003 | 285 | 0.050 |
Why?
|
| Bangladesh | 1 | 2022 | 687 | 0.050 |
Why?
|
| Air Microbiology | 1 | 2000 | 87 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.050 |
Why?
|
| Organ Preservation Solutions | 1 | 2020 | 98 | 0.050 |
Why?
|
| Mice | 3 | 2015 | 81183 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 853 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1375 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 2000 | 245 | 0.040 |
Why?
|
| Fluoroimmunoassay | 1 | 1999 | 33 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 9583 | 0.040 |
Why?
|
| Silicon | 1 | 2000 | 145 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
| Copper | 1 | 2002 | 366 | 0.040 |
Why?
|
| Permeability | 1 | 2021 | 738 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 13989 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2003 | 691 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77449 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 839 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16689 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18029 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
| Gold | 1 | 2002 | 484 | 0.040 |
Why?
|
| Macrolides | 1 | 1999 | 201 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2024 | 41006 | 0.040 |
Why?
|
| Nervous System | 1 | 2021 | 554 | 0.040 |
Why?
|
| Siloxanes | 1 | 1997 | 27 | 0.040 |
Why?
|
| Insecticides | 1 | 1999 | 195 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6365 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8324 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2024 | 13033 | 0.040 |
Why?
|
| Olfactory Receptor Neurons | 1 | 1998 | 92 | 0.040 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1997 | 225 | 0.040 |
Why?
|
| Maine | 1 | 2017 | 139 | 0.040 |
Why?
|
| Fluoresceins | 1 | 1997 | 235 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 1888 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2000 | 676 | 0.040 |
Why?
|
| Ecosystem | 1 | 2021 | 474 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2020 | 772 | 0.040 |
Why?
|
| Systems Biology | 1 | 2020 | 469 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1387 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2000 | 437 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 713 | 0.040 |
Why?
|
| Infant | 3 | 2024 | 35136 | 0.030 |
Why?
|
| Seasons | 1 | 2022 | 1493 | 0.030 |
Why?
|
| Polyhydroxyethyl Methacrylate | 1 | 1995 | 31 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2018 | 383 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2021 | 1189 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2011 | 1572 | 0.030 |
Why?
|
| DNA Damage | 1 | 2005 | 2432 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 1995 | 153 | 0.030 |
Why?
|
| Diffusion | 1 | 1997 | 833 | 0.030 |
Why?
|
| Random Allocation | 1 | 2000 | 2429 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3690 | 0.030 |
Why?
|
| Geography | 1 | 2017 | 669 | 0.030 |
Why?
|
| Rabbits | 1 | 2001 | 4894 | 0.030 |
Why?
|
| Nasal Lavage Fluid | 1 | 2014 | 16 | 0.030 |
Why?
|
| Calcium | 1 | 2007 | 5756 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2021 | 1431 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2866 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4328 | 0.030 |
Why?
|
| Vaccines | 1 | 2022 | 822 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 1470 | 0.030 |
Why?
|
| Buffers | 1 | 1993 | 147 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4803 | 0.030 |
Why?
|
| Leukemia | 1 | 2021 | 1511 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6196 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 4776 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 1736 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2018 | 852 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2012 | 112 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2540 | 0.030 |
Why?
|
| Histatins | 1 | 2011 | 1 | 0.030 |
Why?
|
| Salivary Proline-Rich Proteins | 1 | 2011 | 5 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2012 | 162 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 1997 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2017 | 934 | 0.030 |
Why?
|
| Cell Division | 1 | 1999 | 4568 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 2948 | 0.030 |
Why?
|
| Brain | 1 | 2018 | 26385 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 2421 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15076 | 0.020 |
Why?
|
| Xanthenes | 1 | 1991 | 73 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2001 | 3748 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 1177 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2005 | 4234 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 350 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6933 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 5021 | 0.020 |
Why?
|
| Energy-Generating Resources | 1 | 2009 | 6 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 2957 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1801 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1991 | 1095 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 4740 | 0.020 |
Why?
|
| Genome | 1 | 2017 | 1808 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 634 | 0.020 |
Why?
|
| Acrylates | 1 | 1988 | 89 | 0.020 |
Why?
|
| Arthroplasty, Replacement | 1 | 2012 | 339 | 0.020 |
Why?
|
| Methacrylates | 1 | 1988 | 107 | 0.020 |
Why?
|
| Protein Binding | 1 | 2000 | 9386 | 0.020 |
Why?
|
| Propionates | 1 | 1988 | 169 | 0.020 |
Why?
|
| Acetic Acid | 1 | 1987 | 55 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 791 | 0.020 |
Why?
|
| Alkynes | 1 | 1988 | 306 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1988 | 3760 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 454 | 0.020 |
Why?
|
| TATA Box | 1 | 2006 | 128 | 0.020 |
Why?
|
| Carboxylic Acids | 1 | 1987 | 97 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9146 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 956 | 0.020 |
Why?
|
| Acetates | 1 | 1987 | 311 | 0.020 |
Why?
|
| Phenotype | 2 | 2018 | 16365 | 0.020 |
Why?
|
| Toxicogenetics | 1 | 2005 | 31 | 0.020 |
Why?
|
| Xenobiotics | 1 | 2005 | 73 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1998 | 5391 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 40561 | 0.020 |
Why?
|
| Body Burden | 1 | 2005 | 158 | 0.020 |
Why?
|
| Prevalence | 1 | 2021 | 15226 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2003 | 191 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10180 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2003 | 414 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2012 | 2250 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2006 | 733 | 0.010 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 281 | 0.010 |
Why?
|
| Software | 1 | 1997 | 4443 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 18111 | 0.010 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2012 | 1462 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1987 | 3129 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2010 | 1890 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25625 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 7181 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
| Research | 1 | 2005 | 1999 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 3494 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 53288 | 0.010 |
Why?
|
| Environmental Pollutants | 1 | 2005 | 1179 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15540 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 63114 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1997 | 23403 | 0.010 |
Why?
|
| United States | 1 | 2017 | 69872 | 0.010 |
Why?
|